LSE - Delayed Quote GBp

LungLife AI, Inc. (LLAI.L)

28.00 -3.00 (-9.68%)
At close: April 26 at 4:35 PM GMT+1
Key Events
Loading Chart for LLAI.L
DELL
  • Previous Close 31.00
  • Open 28.00
  • Bid 29.00 x --
  • Ask --
  • Day's Range 28.00 - 28.00
  • 52 Week Range 19.00 - 142.10
  • Volume 20,000
  • Avg. Volume 20,940
  • Market Cap (intraday) 8.584M
  • Beta (5Y Monthly) -0.20
  • PE Ratio (TTM) --
  • EPS (TTM) -0.17
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 2.24

LungLife AI, Inc., a diagnostic company, researches and develops clinical diagnostic solutions for lung cancer with artificial intelligence (AI) technology in the United States and the People's Republic of China. It engages in developing LungLB, a blood-based test to stratify cancerous and benign lung nodules identified by CT scan. The company was formerly known as Cynvenio Biosystems, Inc. and changed its name to LungLife AI, Inc. in May 2019. LungLife AI, Inc. was incorporated in 2009 and is based in Thousand Oaks, California.

lunglifeai.com

15

Full Time Employees

December 31

Fiscal Year Ends

Recent News: LLAI.L

Performance Overview: LLAI.L

Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

LLAI.L
39.13%
FTSE 100
5.26%

1-Year Return

LLAI.L
50.44%
FTSE 100
3.15%

3-Year Return

LLAI.L
--
FTSE 100
15.78%

5-Year Return

LLAI.L
--
FTSE 100
15.78%

Compare To: LLAI.L

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: LLAI.L

Valuation Measures

Annual
As of 4/26/2024
  • Market Cap

    8.58M

  • Enterprise Value

    6.60M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    194.04

  • Price/Book (mrq)

    1.36

  • Enterprise Value/Revenue

    143.48

  • Enterprise Value/EBITDA

    -1.29

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -28.69%

  • Return on Equity (ttm)

    -51.42%

  • Revenue (ttm)

    46k

  • Net Income Avi to Common (ttm)

    -5.41M

  • Diluted EPS (ttm)

    -0.17

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    2.83M

  • Total Debt/Equity (mrq)

    4.37%

  • Levered Free Cash Flow (ttm)

    -3.06M

Research Analysis: LLAI.L

Analyst Price Targets

2.19 Low
2.24 Average
28.00 Current
2.29
 

Fair Value

 

Company Insights: LLAI.L

People Also Watch